Can ruxolitinib tablets (JAKAVI) be taken on an empty stomach and medication recommendations?

Ruxolitinib tablets (JAKAVI, generic name: Ruxolitinib, Ruxolitinib) is a selective JAK1 and JAK2 inhibitors are commonly used to treat diseases such as polycythemia vera, myelofibrosis and graft-versus-host disease (GVHD). In terms of taking method, JAKAVI has good oral bioavailability, so it can be taken on an empty stomach or with food and is not affected by food. Patients can choose to take medicine at a fixed time according to their own living habits, which will help maintain stable blood concentration of the medicine and improve the efficacy.

Although it can be taken on an empty stomach, some patients may experience gastric discomfort, nausea and other reactions in the early stages of taking the drug. Doctors usually recommend taking it with or after meals to reduce gastrointestinal irritation. If obvious discomfort occurs during taking the medicine, it can be relieved by adjusting the time or method of taking the medicine. It is important to take your medication on time every day and avoid missing doses or changing the dose yourself.

The dose of ruxolitinib should be adjusted individually based on the patient's specific condition (such as platelet count, liver and kidney function, etc.). The starting dose is usually 5 mg to 20 mg twice daily. During the medication period, blood routine, liver and kidney function, and symptom changes need to be monitored regularly in order to adjust the dosage or deal with adverse reactions in a timely manner. Do not increase or decrease the dosage or stop the medication on your own to prevent recurrence of the condition or serious side effects.

In short, ruxolitinib tablets are an oral targeted drug that is more flexible in use. It is allowed to be taken on an empty stomach. However, if you have stomach discomfort, it is safer to take it with food. During the treatment period, patients should strictly follow the doctor's instructions, maintain regular medication, and maintain communication with the doctor to ensure the safety and effectiveness of the treatment process.

Reference: https://go.drugbank.com/drugs/